Showing results (2111-2120 of 2,239) with videos related to

Sort By:
Pageof 224
Frontiers in Plant Science|August 23, 2021
The Flower-Infecting Fungus Ustilaginoidea virens Subverts Plant Immunity by Secreting a Chitin-Binding ProteinGuo-Bang Li, Jing Fan, Jin-Long Wu, et al.
Thoracic Cancer|April 8, 2022
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancersJia Tao Zhang, Song Dong, Li Yan Ji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2022
Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety From a Phase 2 Study in People's Republic of ChinaShun Lu, Qing Zhou, Xiaoqing Liu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2020
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)Shun Lu, Jie Wang, Ying Cheng, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 17, 2023
Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancerMeng-Min Wang, Jia-Qi Li, Shi-Hua Dou, et al.
Annals of Nuclear Medicine|December 25, 2023
Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up studyJun-Tao Lin, Xiang-Meng Li, Wen-Zhao Zhong, et al.
JAMA Oncology|June 4, 2023
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical TrialJulien Mazieres, Paul K Paik, Marina C Garassino, et al.
The New England Journal of Medicine|April 10, 2024
Alectinib in Resected ALK-Positive Non-Small-Cell Lung CancerYi-Long Wu, Rafal Dziadziuszko, Jin Seok Ahn, et al.
Plos One|April 25, 2012
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidatesAi-Hsiang Chou, Chia-Chyi Liu, Cheng-Peng Chang, et al.
Oncoimmunology|April 11, 2024
Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinomaXue-Wu Wei, Chang Lu, Yi-Chen Zhang, et al.
Pageof 224